Paper37235366
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Corasaniti MT and 7 others. Toxins (Basel), 2023. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Papers, record 37235366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37235366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Botulinum Toxins, Type A | Major topic |
| Migraine Disorders | Major topic |
| Humans | |
| Randomized Controlled Trials as Topic | |
| Headache |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07040813 | The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy | Background |
Source ClinicalTrials.gov
References129
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34006218 | Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance. | J Headache Pain | 2021 | https://conductscience.org/library/papers/34006218 | PubMed |
| 2 | 27395386 | Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A? | Neurol Sci | 2016 | https://conductscience.org/library/papers/27395386 | PubMed |
| 3 | 30879893 | Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. | Lancet Neurol | 2019 | https://conductscience.org/library/papers/30879893 | PubMed |
| 4 | 35410119 | The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. | J Headache Pain | 2022 | https://conductscience.org/library/papers/35410119 | PubMed |
| 5 | 16772757 | Botulinum toxin type A in prophylactic treatment of migraine. | Am J Ther | 2006 | https://conductscience.org/library/papers/16772757 | PubMed |
| 6 | 31112399 | Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data. | Cephalalgia | 2019 | https://conductscience.org/library/papers/31112399 | PubMed |
| 7 | 21956721 | OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. | Neurology | 2011 | https://conductscience.org/library/papers/21956721 | PubMed |
| 8 | 29306360 | The need for better access to pain treatment: learning from drug consumption trends in the USA. | Funct Neurol | 2017 | https://conductscience.org/library/papers/29306360 | PubMed |
| 9 | 26017508 | Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience. | Neurol Sci | 2015 | https://conductscience.org/library/papers/26017508 | PubMed |
| 10 | 20647171 | OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. | Cephalalgia | 2010 | https://conductscience.org/library/papers/20647171 | PubMed |
| 11 | 12111919 | Quantifying heterogeneity in a meta-analysis. | Stat Med | 2002 | https://conductscience.org/library/papers/12111919 | PubMed |
| 12 | 28529184 | The GRADE Working Group clarifies the construct of certainty of evidence. | J Clin Epidemiol | 2017 | https://conductscience.org/library/papers/28529184 | PubMed |
| 13 | 24107267 | OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program. | Acta Neurol Scand | 2014 | https://conductscience.org/library/papers/24107267 | PubMed |
| 14 | 31559634 | FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine. | Headache | 2019 | https://conductscience.org/library/papers/31559634 | PubMed |
| 15 | 17547312 | Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial. | Aviat Space Environ Med | 2007 | https://conductscience.org/library/papers/17547312 | PubMed |
| 16 | 14687015 | Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. | Cephalalgia | 2004 | https://conductscience.org/library/papers/14687015 | PubMed |
| 17 | 29939406 | Botulinum toxins for the prevention of migraine in adults. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29939406 | PubMed |
| 18 | 19621072 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | PLoS Med | 2009 | https://conductscience.org/library/papers/19621072 | PubMed |
| 19 | 35658247 | Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35658247 | PubMed |
| 20 | 35631592 | Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35631592 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935666 | Procedural interventions for chronic migraine: an umbrella review intervention-specific evidence map. | Front Neurol | 2026 | https://conductscience.org/library/papers/42935666 | PubMed |
| 42640284 | A Three-Point, Low-Dose, Artery-Targeted Botulinum Toxin Treatment for Chronic Migraine: A Randomized, Double-Blind, Contralateral-Controlled Trial. | Aesthetic Plast Surg | 2026 | https://conductscience.org/library/papers/42640284 | PubMed |
| 42460013 | Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42460013 | PubMed |
| 42168840 | Pharmacological mechanisms underlying neurovascular alterations related to resistant and refractory migraine: CGRP pathways and beyond. | J Headache Pain | 2026 | https://conductscience.org/library/papers/42168840 | PubMed |
| 41591179 | Botulinum Toxin Type A for the Prevention of Migraines: An Umbrella Review of Systematic Reviews. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41591179 | PubMed |
| 41484284 | A proof-of-concept study on the effectiveness of botulinum toxin on spasticity plus syndrome in multiple sclerosis. | Neurol Sci | 2026 | https://conductscience.org/library/papers/41484284 | PubMed |
| 40711166 | Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40711166 | PubMed |
| 40693647 | Efficacy of Low-Dose BoNT-A Acupoint Injections in Managing Headache, Vertigo, and Allodynia in Vestibular Migraine. | J Int Adv Otol | 2025 | https://conductscience.org/library/papers/40693647 | PubMed |
| 40559870 | Patient Satisfaction with Aesthetic Outcomes Following OnabotulinumtoxinA Treatment for Chronic Migraine: A Cross-Sectional Study. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40559870 | PubMed |
| 39810518 | Advances in Migraine Treatment: A Comprehensive Clinical Review. | Curr Protein Pept Sci | 2025 | https://conductscience.org/library/papers/39810518 | PubMed |
| 39734637 | Comprehensive list of preventative migraine headache medications without significant drug-drug interactions. | Front Neurol | 2024 | https://conductscience.org/library/papers/39734637 | PubMed |
| 39195765 | The Potential Therapeutic Effects of Botulinum Neurotoxins on Neoplastic Cells: A Comprehensive Review of In Vitro and In Vivo Studies. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/39195765 | PubMed |
| 38962481 | The effectiveness and predictors influencing the outcome of onabotulinumtoxinA treatment in chronic migraine: understanding from diverse patient profiles in a single session. | Front Neurol | 2024 | https://conductscience.org/library/papers/38962481 | PubMed |
| 38910144 | Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis. | J Neurol | 2024 | https://conductscience.org/library/papers/38910144 | PubMed |
| 38441599 | Subjective Discomfort during Botulinumtoxin Injections Dependent on Injection Site and Needle Size: A Comparison Between 30G, 33G and 34G Needles. | Aesthetic Plast Surg | 2024 | https://conductscience.org/library/papers/38441599 | PubMed |
| 38409723 | Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril? | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38409723 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALCA | 796 | PubTator's text mining | https://conductscience.org/library/genes/796 | NCBI Gene |
| CX3CL1 | 6376 | PubTator's text mining | https://conductscience.org/library/genes/6376 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| MYD88 | 4615 | PubTator's text mining | https://conductscience.org/library/genes/4615 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| SNAP25 | 6616 | PubTator's text mining | https://conductscience.org/library/genes/6616 | NCBI Gene |
| TAC1 | 6863 | PubTator's text mining | https://conductscience.org/library/genes/6863 | NCBI Gene |
| TLR2 | 7097 | PubTator's text mining | https://conductscience.org/library/genes/7097 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37235366
GET https://conductscience.org/api/papers/v1/37235366/references?page=2